<SEC-DOCUMENT>0000882095-23-000019.txt : 20230505
<SEC-HEADER>0000882095-23-000019.hdr.sgml : 20230505
<ACCEPTANCE-DATETIME>20230505111524
ACCESSION NUMBER:		0000882095-23-000019
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230503
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230505
DATE AS OF CHANGE:		20230505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GILEAD SCIENCES, INC.
		CENTRAL INDEX KEY:			0000882095
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943047598
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19731
		FILM NUMBER:		23892050

	BUSINESS ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6505743000

	MAIL ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILEAD SCIENCES INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gild-20230503.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:d514cf5c-b880-44be-997f-54690199e6c4,g:a54f0be9-39c2-46b5-91a9-6713ada5b3a2,d:833ebbc5a0914c4db43c1d876e16b434--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>gild-20230503</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF80L2ZyYWc6ZTBhZDUwODIwYTMyNGY2MWE4YWJlOTUxMzQ2MzY2NjEvdGFibGU6OGFlODg2YjZjMjQyNGQwMWE4Y2EwZmQxM2MzODdkY2MvdGFibGVyYW5nZTo4YWU4ODZiNmMyNDI0ZDAxYThjYTBmZDEzYzM4N2RjY18xLTEtMS0xLTMwODQ4Mg_d5d383e6-3224-4ae4-8c80-c6aaea7262d0">0000882095</ix:nonNumeric><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF80L2ZyYWc6ZTBhZDUwODIwYTMyNGY2MWE4YWJlOTUxMzQ2MzY2NjEvdGFibGU6OGFlODg2YjZjMjQyNGQwMWE4Y2EwZmQxM2MzODdkY2MvdGFibGVyYW5nZTo4YWU4ODZiNmMyNDI0ZDAxYThjYTBmZDEzYzM4N2RjY18yLTEtMS0xLTMwODQ4Mg_d43ad4c9-f3f2-4bb9-bff0-fea90e469551">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="gild-20230503.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-03</xbrli:startDate><xbrli:endDate>2023-05-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i833ebbc5a0914c4db43c1d876e16b434_1"></div><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV84OQ_2dd9e29f-d8d1-4f12-b6cc-00d4a7f0ec0f">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934 </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV81NDk3NTU4MTc1NjM_a7e3584b-4307-4fae-9cb8-52e571cca145">May&#160;3, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.501%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8yNDA_b0454b7d-d408-40d1-97f6-5c64dc915cba">GILEAD SCIENCES, INC.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter) </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6NDI5NDliMzBlY2JjNGJhMDg4MzU5Mjk3Y2VlZmQ1YWYvdGFibGVyYW5nZTo0Mjk0OWIzMGVjYmM0YmEwODgzNTkyOTdjZWVmZDVhZl8wLTAtMS0xLTMwODQ4Mg_fe821509-fe5e-41f0-9ac0-5935f1f3cd75">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6NDI5NDliMzBlY2JjNGJhMDg4MzU5Mjk3Y2VlZmQ1YWYvdGFibGVyYW5nZTo0Mjk0OWIzMGVjYmM0YmEwODgzNTkyOTdjZWVmZDVhZl8wLTEtMS0xLTMwODQ4Mg_f0442b00-67e0-4f13-846e-a2806215d093">0-19731</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6NDI5NDliMzBlY2JjNGJhMDg4MzU5Mjk3Y2VlZmQ1YWYvdGFibGVyYW5nZTo0Mjk0OWIzMGVjYmM0YmEwODgzNTkyOTdjZWVmZDVhZl8wLTItMS0xLTMwODQ4Mg_587615b2-4633-4a8b-8eb8-76240009b9f7">94-3047598</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File No.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zMDI_b6d81d9e-3780-4723-932b-ae43e8e96126">333 Lakeside Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zMDY_93abd0e1-872e-4f82-9cd7-3d6e37594905">Foster City</ix:nonNumeric>, <ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zMTA_1e19fdc0-b35d-4fc1-85fa-92d54a55b5b0">California</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNTU_faa03282-1d12-4e28-ba69-3506c3211ad2">94404</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Zip Code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNzA_f06f9b25-4471-407f-83ba-628e562d4de6">650</ix:nonNumeric>-<ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNzM_6d5870d3-156f-4f7d-8e5c-3fd060859b5e">574-3000</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.501%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjYx_63ef027e-f08e-4b6c-aeec-0485a1a10a68">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjYy_9843df0c-f3be-4122-9242-502f01d2ef06">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjYz_5f61a772-0d4d-4c3f-a4fb-1f7833297d33">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjY0_d47f46c6-74f6-420b-b43f-069db62b227f">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6MDFkYWVkZjQwN2JmNGJlMmJjYzJiNmI3MThmZWUzNmEvdGFibGVyYW5nZTowMWRhZWRmNDA3YmY0YmUyYmNjMmI2YjcxOGZlZTM2YV8xLTAtMS0xLTMwODQ4Mg_67f5ba89-c816-4a3b-a62b-20fce0eea628">Common Stock, par value, $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6MDFkYWVkZjQwN2JmNGJlMmJjYzJiNmI3MThmZWUzNmEvdGFibGVyYW5nZTowMWRhZWRmNDA3YmY0YmUyYmNjMmI2YjcxOGZlZTM2YV8xLTItMS0xLTMwODQ4Mg_555c596f-197f-4c76-acac-d02071694e0e">GILD</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6MDFkYWVkZjQwN2JmNGJlMmJjYzJiNmI3MThmZWUzNmEvdGFibGVyYW5nZTowMWRhZWRmNDA3YmY0YmUyYmNjMmI2YjcxOGZlZTM2YV8xLTQtMS0xLTMwODQ4Mg_8f295490-0041-4c94-9faf-95a682ee322d">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjU4_1d7975ba-9b4e-4705-8b4f-dce5dd6a3725">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Approval of an Amendment and Restatement of the Gilead Sciences, Inc. Employee Stock Purchase Plan and the Gilead Sciences, Inc. International Employee Stock Purchase Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2023, the Board of Directors (the &#8220;Board&#8221;) of Gilead Sciences, Inc. (&#8220;Gilead&#8221;) approved an amendment and restatement of the Gilead Sciences, Inc. Employee Stock Purchase Plan (the &#8220;Purchase Plan&#8221;) and an amendment and restatement of the Gilead Sciences, Inc. International Employee Stock Purchase Plan (the &#8220;International Purchase Plan,&#8221; and together with the Purchase Plan, the &#8220;Plans&#8221;), subject to stockholder approval. A summary of the principal features of the Plans is set forth under Proposal 5 of Gilead&#8217;s definitive proxy statement filed with the Securities and Exchange Commission on March 23, 2023 (the &#8220;Proxy Statement&#8221;), which description is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plans were approved by Gilead&#8217;s stockholders at the 2023 Annual Meeting of Stockholders on <ix:nonNumeric contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV81NDk3NTU4MzM0NDg_a7e3584b-4307-4fae-9cb8-52e571cca145">May&#160;3, 2023</ix:nonNumeric> (the &#8220;Annual Meeting&#8221;). The foregoing summary of the Plans does not purport to be complete and is qualified in its entirety by reference to the provisions of the Purchase Plan and the International Purchase Plan, which are attached to this Current Report on Form 8-K as </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex1012023employeestockpurc.htm">Exhibit 10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex1022023internationalempl.htm">Exhibit 10.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and are incorporated by reference herein.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07&#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Annual Meeting was held on May 3, 2023. Of the 1,248,816,053 shares of the Company&#8217;s common stock entitled to vote at the Annual Meeting, 1,112,399,050 shares were represented at the meeting in person or by proxy, constituting a quorum. The voting results are presented below.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders elected nine directors to serve for the next year and until their successors are elected and qualified, or until their earlier death, resignation or removal. The votes regarding the election of directors were as follows:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:27.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacqueline K. Barton, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986,415,013&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,491,911&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,001,479&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Bluestone, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,919,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,943,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra J. Horning, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981,121,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,770,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,016,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kelly A. Kramer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966,965,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,909,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin E. Lofton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925,933,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,885,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harish Manwani</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959,762,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,053,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel P. O&#8217;Day</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,236,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,663,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Javier J. Rodriguez</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993,470,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,361,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anthony Welters</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952,610,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,579,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,718,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders ratified the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2023. The proposal received the following votes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.836%"><tr><td style="width:1.0%"></td><td style="width:60.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047,348,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes Against</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,802,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders approved, on an advisory basis, the compensation of the Company&#8217;s Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.836%"><tr><td style="width:1.0%"></td><td style="width:60.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919,145,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes Against</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,500,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders voted, on an advisory basis, on the frequency of future advisory stockholder votes on executive compensation. The frequency receiving the most votes was 1 Year. The proposal received the following votes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.836%"><tr><td style="width:1.0%"></td><td style="width:60.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,408,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 Years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,113,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Board&#8217;s recommendation as set forth in the Proxy Statement and consistent with the stated preference of the Company&#8217;s stockholders, the Company has determined that future advisory stockholder votes on executive compensation will be conducted on an annual basis, until the next advisory vote on this matter is held.</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders approved an amendment and restatement of the Gilead Sciences, Inc. Employee Stock Purchase Plan and the Gilead Sciences, Inc. International Employee Stock Purchase Plan. The proposal received the following votes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.836%"><tr><td style="width:1.0%"></td><td style="width:60.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996,900,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes Against</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,074,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders did not approve a stockholder proposal requesting the Board implement a process to nominate at least one more candidate than the number of directors to be elected. The proposal received the following votes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.836%"><tr><td style="width:1.0%"></td><td style="width:60.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,422,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes Against</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982,909,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,576,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders did not approve a stockholder proposal requesting the Board amend the company governing documents to give street name shares and non-street name shares an equal right to call a special stockholder meeting. The proposal received the following votes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.836%"><tr><td style="width:1.0%"></td><td style="width:60.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,426,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes Against</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940,591,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,890,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders did not approve a stockholder proposal requesting a report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents. The proposal received the following votes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.836%"><tr><td style="width:1.0%"></td><td style="width:60.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,422,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Votes Against</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824,383,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,102,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,490,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1012023employeestockpurc.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1012023employeestockpurc.htm">Gilead Sciences, Inc. Employee Stock Purchase Plan, amended and restated January 25, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1022023internationalempl.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1022023internationalempl.htm">Gilead Sciences, Inc. International Employee Stock Purchase Plan, amended and restated January 25, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.836%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GILEAD SCIENCES, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DEBORAH H. TELMAN</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deborah H. Telman<br/>EVP, Corporate Affairs, General Counsel and Corporate Secretary</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date:  May&#160;5, 2023</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex1012023employeestockpurc.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if0d6ab29cc8a4619b379632c52287ac5_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Exhibit 10.1 </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:18pt;font-weight:700;line-height:120%">  </font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GILEAD SCIENCES, INC.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMPLOYEE STOCK PURCHASE PLAN</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(as Amended and Restated January 25, 2023)</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Termination Date&#58; January 25, 2033</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt">Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> The purpose of the Employee Stock Purchase Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) is to provide a means by which employees of Gilead Sciences, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and its participating Affiliates (as defined in subparagraph 1(c)) may be given an opportunity to purchase stock of the Company pursuant to a plan that qualifies as an employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The Plan initially was adopted on November 15, 1991. The Plan has been amended and restated on several subsequent occasions, and each offering under the Plan has been subject to the terms and provisions of the Plan in force and effect on the start date of that offering. Effective November 3, 2009, the Plan was amended and restated in its entirety, and subsequent to such date the maximum number of shares of the Company&#8217;s common stock reserved for issuance under the Plan, as so amended and restated, are reduced, on a one-for-one basis, by the number of shares of the Company&#8217;s common stock issued under the Company&#8217;s International Employee Stock Purchase Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">International Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). The Plan has been most recently amended and restated in its entirety effective as of January 25, 2023.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; as used in the Plan means any parent corporation or subsidiary corporation of the Company, as those terms are defined in Sections 424(e) and (f), respectively, of the Code. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The Company, by means of the Plan, seeks to retain the services of its employees and employees of its Affiliates, to secure and retain the services of new employees, and to provide incentives for such persons to exert maximum efforts for the success of the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> The Company intends that the rights to purchase stock of the Company granted under the Plan be considered options issued under an &#8220;employee stock purchase plan&#8221; as that term is defined in Section 423(b) of the Code, although the Company makes no undertaking or representation to maintain such qualification. The provisions of the Plan shall be construed, administered and enforced in accordance with Section 423(b) of the Code. The Company may also grant rights to purchase stock under the International Plan that are not intended to meet the requirements of Section 423(b) of the Code, pursuant to rules, procedures or sub-plans adopted by the Company under such plan and designed to achieve tax, securities law or other objectives in one or more jurisdictions outside the United States, provided that (i) eligible employees (as that term is described in paragraph 5) who reside in the United States and are employed by the Company or an Affiliate located in the United States will not be granted rights to purchase stock under the International Plan and (ii) eligible employees of Related Entities (as such term is defined in the International Plan), whether or not located in the United States, will not be granted rights to purchase stock under the Plan. Except to the limited extent otherwise provided in the International Plan, the purchase rights granted under that plan will be subject to the same terms, provisions and restrictions as in effect for the purchase rights granted under the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> The Plan shall be administered by the Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) of the Company unless and until the Board delegates administration to a Committee, as provided in subparagraph 2(c). Whether or not the Board has delegated administration, the Board shall have the final power to determine all questions of policy and expediency that may arise in the administration of the Plan. All determinations of the Board or the Committee shall be final, conclusive and binding on all persons and otherwise accorded the maximum deference permitted by law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The Board shall have the power, subject to, and within the limitations of, the express provisions of the Plan&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:42.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;To determine when and how rights to purchase stock of the Company shall be granted and the provisions to be in effect for each offering of such rights (with no need for the provisions of each offering to be identical).</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:39.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  &#160;&#160;&#160;&#160;To designate from time to time which Affiliates shall be eligible to participate in the Plan.</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:36.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  &#160;&#160;&#160;&#160;To construe and interpret the Plan and rights granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective. </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:36.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  &#160;&#160;&#160;&#160;To amend the Plan as provided in paragraph 13.</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:40.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  &#160;&#160;&#160;&#160;Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> The Board may delegate administration of the Plan to a committee composed of not fewer than two (2) members of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). If administration is delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the powers theretofore possessed by the Board, subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The Board (or the Committee, as appropriate) may, from time to time, employ an entity unrelated to the Company to assist with administration, recordkeeping and other ministerial duties in connection with the Plan (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Third Party Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Shares Subject To The Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Subject to the provisions of paragraph 12 relating to adjustments upon changes in stock, the total number of shares that may be sold pursuant to rights granted under the Plan shall not exceed in the aggregate the 103,560,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:112%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> shares of the Company&#8217;s $0.001 par value common stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) that the Company&#8217;s stockholders have approved for issuance under the Plan. Shares of Common Stock sold pursuant to rights granted under the Plan shall reduce, on a one-for-one basis, the number of shares remaining available for sale and issuance under the Plan. In addition, any shares of Common Stock sold pursuant to rights granted under the International Plan shall also reduce, on a one-for-one basis, the number of shares available for sale and issuance under the Plan. If any right granted under the Plan shall for any reason terminate without having been exercised, the Common Stock not purchased under such right shall again become available for issuance under the Plan, unless otherwise issued under the International Plan. The Common Stock issuable under the Plan may be unissued shares or reacquired shares, bought on the market or otherwise.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Grant Of Rights&#59; Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Board or the Committee may from time to time grant or provide for the grant of rights to purchase Common Stock under the Plan to eligible employees (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) on a date or dates (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Offering Date(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) selected by the Board or the Committee. Each Offering shall be in such form and shall contain such terms and conditions as the Board or the Committee shall deem appropriate. The provisions of separate Offerings need not be identical, but each Offering shall include (through incorporation of the provisions of the Plan by reference in the Offering or otherwise) the substance of the provisions contained in paragraphs 5 through 8, inclusive.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> Rights may be granted only to employees of the Company or, to employees of any Affiliate designated by the Board or the Committee as provided in subparagraph 2(b). Except as provided in subparagraph 5(b), an employee of the Company or any designated Affiliate shall not be eligible to be granted rights under the Plan, unless, on the Offering Date, such employee has been in the employ of the Company or one or more Affiliates for such continuous period preceding the grant date as the Board or the Committee may require, but in no event shall the required period of continuous employment be equal to or greater than two (2) years. In addition, unless otherwise determined by the Board or the Committee and set forth in the terms of the applicable Offering, no employee of the Company or any designated Affiliate shall be eligible to be granted rights under the Plan, unless, on the Offering Date, such employee&#8217;s customary employment with the Company or such designated Affiliate is at least twenty (20) hours per week and at least five (5) months per calendar year. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The Board or the Committee may provide that, each person who, during the course of an Offering, first becomes an eligible employee of the Company or of any designated Affiliate will, on a date or dates specified in the Offering which coincides with the day on which such person becomes an eligible employee or occurs thereafter, receive a right under that Offering, which right shall </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;Share reserve </font><font style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">consists of 4,000,000 shares authorized in November 15, 1991, when the Plan was originally adopted, an additional 8,000,000 shares authorized on May 24, 1994, an additional 8,000,000 authorized on May 27, 1998, an additional 5,280,000 shares authorized on July 29, 1999, an additional 8,000,000 shares authorized on May 9, 2007, an additional 33,280,000 shares authorized on November 3, 2009, an additional 12,000,000 shares authorized on May 6, 2015, and an additional 25,000,000 shares to be submitted for stockholder approval and authorized at the Company&#8217;s 2023 annual meeting of stockholders. The share amounts so indicated have been adjusted to reflect the five (5) two-for-one stock splits of the Common Stock effected in February 2001, March 2002, September 2004, June 2007 and January 2013, respectively.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">thereafter be deemed to be a part of that Offering. Such right shall have the same characteristics as any rights originally granted under that Offering, as described herein, except that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:42.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;the date on which such right is granted shall be the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Offering Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; of such right for all purposes, including determination of the exercise price of such right&#59; </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:39.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;the Offering Period (as defined in subparagraph 6(a)) for such right shall begin on its Offering Date and end coincident with the end of such Offering&#59; </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:36.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;the Offering Date shall constitute the beginning of a Purchase Period&#59; and </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:36.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;the Board or the Committee may provide that if such person first becomes an eligible employee within a specified period of time before the end of the Offering Period (as defined in subparagraph 6(a)) for such Offering, he or she will not receive any right under that Offering.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> No employee shall be eligible for the grant of any rights under the Plan if, immediately after any such rights are granted, such employee owns stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or of any Affiliate. For purposes of this subparagraph 5(c), the rules of Section 424(d) of the Code shall apply in determining the stock ownership of any employee, and stock which such employee may purchase under all outstanding rights and options shall be treated as stock owned by such employee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> An eligible employee may be granted rights under the Plan only if such rights, together with any other rights granted to such employee under &#8220;employee stock purchase plans&#8221; of the Company and any Affiliate, as specified by Section 423(b)(8) of the Code, do not permit such employee&#8217;s rights to purchase Common Stock of the Company or any Affiliate to accrue at a rate which exceeds U.S. twenty-five thousand dollars (U.S. $25,000) of fair market value of such Common Stock (determined at the time such rights are granted) for each calendar year in which such rights are outstanding at any time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> Officers of the Company and any designated Affiliate shall be eligible to participate in Offerings under the Plan, provided, however, that the Board may provide in an Offering that all or certain employees who are highly compensated employees within the meaning of Section 423(b)(4)(D) of the Code shall not be eligible to participate.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Rights&#59; Purchase Price.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> On each Offering Date, each eligible employee, pursuant to an Offering made under the Plan, shall be granted the right to purchase the number of shares of Common Stock purchasable with up to twenty percent (20%) (or such other percentage as the Board or the Committee determines for a particular Offering) of such employee&#8217;s Earnings (as defined in subparagraph 7(b)) during the period which begins on the Offering Date (or such later date as the Board or the Committee determines for a particular Offering) and ends on the date stated in the Offering, which date shall be no more than twenty-seven (27) months after the Offering Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Offering Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). In connection with each Offering made under the Plan, the Board or the Committee shall specify a maximum number of shares which may be purchased by any employee and a maximum aggregate number of shares which may be purchased by all eligible employees pursuant to such Offering. Each Offering Period may contain more than one exercise date, as defined in the relevant Offering (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Exercise Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), in which case there will be multiple &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Purchase Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">,&#8221; the first commencing with the Offering Date and ending with the first Exercise Date of that Offering and subsequent ones commencing with the first day following the immediately preceding Exercise Date and ending with the next Exercise Date of that </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Offering. Where an Offering contains more than one Exercise Date, the Board or the Committee may, prior to the start of that Offering, specify a maximum number of shares which may be purchased by any employee on each such Exercise Date within such Offering and a maximum aggregate number of shares which may be purchased by all eligible employees on such Exercise Date. If the aggregate purchase of shares upon exercise of rights granted under the Offering would exceed any such maximum aggregate number, the Board or the Committee shall make a pro rata allocation of the shares available in as nearly a uniform manner as shall be equitable and practicable under the circumstances.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The purchase price of Common Stock acquired pursuant to rights granted under the Plan shall be equal to eighty-five percent (85%) of the lower of&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:42.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;the Fair Market Value per share of Common Stock on the start of the Offering Period&#59; or </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:39.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;the Fair Market Value per share of Common Stock on the Exercise Date. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> As of any date, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; is defined as the closing sales price for the Common Stock (or the closing bid, if no sales were reported) on such day as quoted on The Nasdaq Global Select Market or as reported by such other source as the Board deems reliable. If there are no quotations for the relevant day, &#8220;Fair Market Value&#8221; is defined with reference to the most recent preceding date on which there are quotations. </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Participation&#59; Withdrawal&#59; Termination.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> An eligible employee may become a participant in an Offering by submitting an enrollment form to the Company, in a form approved by the Company, or by accessing the Third Party Administrator&#8217;s website and electronically enrolling within the Offering on or before his or her applicable Offering Date for that Offering (or any earlier enrollment deadline specified by the Company). During such enrollment process, the employee shall authorize payroll deductions of up to twenty percent (20%) (or such other percentage as the Board or the Committee determines for a particular Offering) of such employee&#8217;s Earnings (as defined in subparagraph 7(b)) during the Offering Period. The payroll deductions made for each participant shall be credited to an account for such participant under the Plan and shall be deposited with the general funds of the Company. A participant may reduce, increase or begin payroll deductions after the beginning of any Offering Period only as provided for in that Offering. A participant may make additional payments into his or her account only if specifically provided for in the Offering and only if the participant has not had the maximum amount withheld during the Offering Period.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Earnings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; is defined as an employee&#8217;s total compensation, including (i) all salary, wages and other remuneration paid to the employee (including amounts elected to be deferred or contributed under any cash or deferred arrangement or cafeteria benefit plan maintained by the Company (or any participating Affiliate) pursuant to Sections 401(k) and 125, respectively, of the Code) and (ii) overtime pay, commissions, bonuses, profit sharing and any special payments for extraordinary services.  However, &#8220;Earnings&#8221; shall not include the cost of employee benefits paid by the Company or any Affiliate, education or tuition fee reimbursements, imputed income arising under any group insurance or other employee benefit program, reimbursement of traveling, business or moving expenses, income realized in connection with stock options or other equity awards, amounts elected to be deferred under any nonqualified deferred compensation plan established by the Company or any Affiliate and referral pay which is paid in recognition of referring an employee candidate. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> At any time during an Offering Period a participant may terminate his or her payroll deductions under the Plan and withdraw from the Offering by submitting a withdrawal notice to the Company or by accessing the Third Party Administrator&#8217;s website and electronically electing to </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">withdraw. Such withdrawal may be elected at any time prior to the end of the Purchase Period (or any earlier withdrawal deadline specified by the Company). Upon such withdrawal from the Offering by a participant, the Company shall distribute to such participant all of his or her accumulated payroll deductions (reduced to the extent, if any, such deductions have been used to acquire shares for the participant) under the Offering, without interest unless the terms of the Offering specifically so provide, and such participant&#8217;s interest in that Offering shall be automatically terminated. A participant&#8217;s withdrawal from an Offering will have no effect upon such participant&#8217;s eligibility to participate in any other future Offerings under the Plan but such participant will be required to re-enroll in order to participate in subsequent Offerings under the Plan. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> Except as provided in Section 7(f) below, rights granted pursuant to any Offering under the Plan shall terminate immediately upon cessation of any participating employee&#8217;s employment with the Company or any participating Affiliates for any reason, and the Company shall distribute to such terminated employee all of his or her accumulated payroll deductions (reduced to the extent, if any, such deductions have been used to acquire shares for the terminated employee) under the Offering, without interest unless the terms of the Offering specifically so provide.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> Should a participating employee cease to remain in active service by reason of an approved unpaid leave of absence, then such employee shall have the right, exercisable up until the last business day of the Purchase Period (or any earlier deadline specified by the Company) in which such leave commences, to (a) withdraw all the payroll deductions collected to date on his or her behalf for that Purchase Period or (b) have such funds held for the purchase of shares on his or her behalf on the next scheduled Exercise Date. If the participating employee fails to make a timely election, the accumulated payroll deductions will automatically be applied to the purchase of shares on his or her behalf on the next scheduled Exercise Date. In no event, however, shall any further payroll deductions be collected on the employee&#8217;s behalf during such leave. Upon the participating employee&#8217;s return to active service (i) within three (3) months following the commencement of such leave or (ii) prior to the expiration of any longer period for which such employee had reemployment rights with the Company or any participating Affiliate provided by either statute or contract, his or her payroll deductions under the Plan shall automatically resume at the rate in effect at the time the leave began, unless the employee withdraws from the Plan prior to his or her return. An employee who returns to active employment following a leave of absence that exceeds in duration the applicable time period set forth in (i) or (ii) above shall be treated as a new employee for purposes of subsequent participation in the Plan and must accordingly re-enroll in the Plan in order to participate in subsequent Offerings under the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.03pt"> Notwithstanding anything to the contrary contained herein, a participating employee who transfers employment from the Company or any Affiliate participating in the Plan to an Affiliate or Related Entity participating in the International Plan shall immediately cease to participate in the Plan. However, his or her accumulated payroll deductions for the Purchase Period in which such transfer occurs shall be transferred to the International Plan, and such individual shall immediately join the then current Offering under the International Plan upon the same terms and conditions in effect for his or her participation in the Plan, except for such modifications as may be required by applicable local law. A participating employee who transfers employment from an Affiliate or Related Entity participating in a current Offering under the International Plan to the Company or any other Affiliate participating in the Plan shall remain a participant in the International Plan until the earlier of (i) the end of the current Offering Period under the International Plan or (ii) the start date of the first Offering under the Plan in which he or she participates following such transfer.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> Rights granted under the Plan shall not be transferable by a participant otherwise than by will or the laws of descent and distribution, or by a beneficiary designation as provided in </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">paragraph 14 and, otherwise during his or her lifetime, shall be exercisable only by the person to whom such rights are granted.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Exercise and Delivery. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> On each Exercise Date, each participant&#8217;s accumulated contributions (without any increase for interest unless the terms of the Offering specifically so provide) will be applied to the purchase of shares of Common Stock of the Company, up to the maximum number of shares permitted pursuant to the terms of the Plan and the applicable Offering, at the purchase price specified in the Offering. No fractional shares shall be issued upon the exercise of rights granted under the Plan unless otherwise determined by the Board or the Committee. The amount, if any, of remaining accumulated contributions after the purchase of shares which is less than the amount required to purchase one share of Common Stock on any current Exercise Date within an Offering shall be refunded to such participant as soon as administratively practicable following such Exercise Date, without interest unless the terms of the Offering specifically so provide.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> No rights granted under the Plan may be exercised to any extent unless the Plan (including rights granted thereunder) is covered by an effective registration statement pursuant to the U.S. Securities Act of 1933, as amended. If on an Exercise Date of any Offering hereunder the Plan (and all rights granted thereunder) is not so registered, no rights granted under the Plan or any Offering shall be exercised on such Exercise Date, and all payroll deductions accumulated during the Purchase Period ending on such Exercise Date (reduced to the extent, if any, such deductions have been used to acquire shares) shall be distributed to the participants, without interest, unless the terms of the Offering specifically so provide.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt"> As soon as administratively practicable following the Exercise Date, the Company shall deliver to each participant the shares of Common Stock purchased with such participant&#8217;s accumulated contributions in a form determined by the Board or the Committee, in its discretion, including, without limitation, through the transfer of the shares to the participant in book-entry form or through an alternative arrangement to a recordkeeping service (and the Board or the Committee may either require or permit participants to elect that certificates representing such shares be delivered to such recordkeeping service).  The Board or the Committee, in its discretion, may either require or permit that shares of Common Stock purchased with each participant&#8217;s accumulated contributions be deposited directly with a broker designated by the Board or the Committee (or its delegate) and may either require or permit that such shares be retained with such broker for a designated period of time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The Company or its designee may make such provisions and take such action as it deems necessary or appropriate for the withholding of taxes or other amounts which the Company is required to withhold by applicable law. Each Participant, however, shall be responsible for payment of all individual tax liabilities arising under the Plan.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Covenants of the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> While rights granted under the Plan remain outstanding, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such rights.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The Company shall seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to issue and sell shares of Common Stock upon exercise of the rights granted under the Plan. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of shares under the Plan, the Company shall be relieved from any liability for failure to issue and sell shares upon exercise of such rights unless and until such authority is obtained.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Accumulated Payroll Deductions.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A participant&#8217;s accumulated payroll deductions are part of the general funds of the Company and do not earn interest, unless the terms of the Offering specifically so provide. </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Rights As A Stockholder.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A participant shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares subject to rights granted under the Plan unless and until certificates representing such shares shall have been issued or recorded in the books of the Company (or its transfer agent).</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Adjustments Upon Changes In Stock.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> If any change is made in the securities subject to the Plan, or subject to any rights granted under the Plan (through merger, consolidation, reorganization, recapitalization, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or otherwise), the Plan and the outstanding rights thereunder will be appropriately adjusted as to the class(es) and maximum number of securities subject to the Plan and the class(es) and number of securities and price per share subject to each outstanding purchase right.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> In the event of a  Change in Control (as such term is defined in the Gilead Sciences, Inc. 2022 Equity Incentive Plan or any successor plan thereto), then, as determined by the Board in its sole discretion (i) any surviving corporation may assume outstanding rights or substitute similar rights for those under the Plan, (ii) such rights may continue in full force and effect, (iii) the accumulated payroll deductions may be used to purchase shares of Common Stock immediately prior to the transaction described above and the rights of participants under the ongoing Offering shall be terminated, or (iv) all outstanding Offering Periods may be terminated immediately as of such date specified by the Board and all participants&#8217; accumulated contributions that have not been used to purchase shares of Common Stock be returned to the participants (without interest unless the terms of the Offering specifically so provide) as soon as administratively practicable thereafter. </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Amendment Of The Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> The Board at any time, and from time to time, may amend the Plan, including to re-combine the International Plan with the Plan. However, except as provided in paragraph 12 relating to adjustments upon certain changes to the Common Stock, no amendment shall be effective unless approved by the stockholders of the Company within twelve (12) months before or after the adoption of the amendment, where the amendment will&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:42.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;Increase the total number of shares reserved for issuance and sale in the aggregate under the Plan and the International Plan&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:39.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;Modify the provisions as to eligibility for participation in the Plan (to the extent such modification requires stockholder approval in order for the Plan to maintain employee stock purchase plan treatment under Section 423 of the Code or to comply with any applicable Nasdaq or securities exchange listing requirements)&#59; or </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:36.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#160;&#160;&#160;&#160;Modify the Plan in any other way if such modification requires stockholder approval in order for the Plan to maintain employee stock purchase plan </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">treatment under Section 423 of the Code or to comply with any applicable Nasdaq or securities exchange listing requirements.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Board may, in its sole discretion, submit any other amendment to the Plan for stockholder approval. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide eligible employees with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated thereunder relating to employee stock purchase plans and&#47;or to bring the Plan and&#47;or rights granted under it into compliance therewith.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> Rights and obligations under any rights granted before amendment of the Plan shall not be materially and adversely altered or impaired by any amendment of the Plan, except with the consent of the person to whom such rights were granted or except as necessary to comply with applicable laws or governmental regulations or to ensure that the Plan and&#47;or rights granted thereunder comply with the requirements of Section 423 of the Code. </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Designation Of Beneficiary.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> A participant may file (i) with the Company on a form provided by the Company, a written designation of a beneficiary who is to receive any accumulated payroll deductions (reduced to the extent, if any, such deductions have been used to acquire shares for the deceased employee), without interest unless the terms of the Offering specifically so provide, in the event of such participant&#8217;s death during an Offering, and (ii) with a broker designated by the Board or the Committee on a form provided by such broker, a written designation of a beneficiary who is to receive any shares of Common Stock purchased under the Plan and held by such broker on participant&#8217;s behalf.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> The participant may change such designation of beneficiary at any time by written notice to the Company in the form provided by the Company (or to such broker in the form provided by the broker, as applicable). In the event of the death of a participant in the absence of a beneficiary validly designated under the Plan who is living at the time of such participant&#8217;s death, the Company shall deliver any accumulated payroll deductions (reduced to the extent, if any, such deductions have been used to acquire shares for the deceased employee), without interest unless the terms of the Offering specifically so provide, to the executor or administrator of the estate of the participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver such accumulated payroll deductions to the spouse or to any one or more dependents or relatives of the participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate or determine to be the appropriate recipient of such accumulated payroll deductions under applicable law.  In the absence of a designated beneficiary with the broker holding any shares of Common Stock purchased under the Plan, the broker&#8217;s policies for distribution of such shares shall apply.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Termination Or Suspension Of The Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt"> The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate ten (10) years from the date the Plan (as herein amended and restated) was adopted by the Board or approved by the stockholders of the Company, whichever was earlier. No rights may be granted under the Plan while the Plan is suspended or after it is terminated.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.35pt"> Rights and obligations under any rights granted while the Plan is in effect shall not be impaired by suspension or termination of the Plan, except as expressly provided in the Plan or with the consent of the person to whom such rights were granted, or except as necessary to comply with </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">applicable laws or governmental regulation or to ensure that the Plan and&#47;or rights granted thereunder comply with the requirements of Section 423 of the Code.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Severability.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If any particular provision of the Plan is found to be invalid or unenforceable, such provision shall not affect the other provisions of the Plan, but the Plan shall be construed in all respects as if such invalid provision had been omitted.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Governing Law.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Except to the extent that provisions of the Plan are governed by applicable provisions of the Code or any other substantive provision of U.S. federal law, the Plan shall be construed in accordance with, and shall be governed by, the substantive laws of the State of Delaware without resort to Delaware&#8217;s conflict-of-laws rules. </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:3pt">Effective Date Of Plan.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Plan (as herein amended and restated) shall become effective as determined by the Board, but no rights granted under the Plan, as amended and restated herein, shall be exercised unless and until the stockholders of the Company have approved the Plan.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex1022023internationalempl.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ieefb7e7e035440faaef864957702a6d9_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Exhibit 10.2</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:18pt;font-weight:700;line-height:120%"> </font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">GILEAD SCIENCES, INC.</font></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN</font></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(as Amended and Restated January 25, 2023)</font></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Termination Date&#58; January 25, 2033</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">1.   Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The purpose of the International Employee Stock Purchase Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) is to provide a means by which employees of participating Affiliates and Related Entities (both as defined in subparagraph 1(c)), who reside in jurisdictions outside the United States may be given an opportunity to purchase stock of Gilead Sciences, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Plan and the Company&#8217;s Employee Stock Purchase Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 423 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), an employee stock purchase plan maintained under Section 423 of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), share the reserve of the Company&#8217;s $0.001 par value common stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) approved by the Company&#8217;s stockholders for issuance under the Section 423 Plan.  Accordingly, the maximum number of shares of the Company&#8217;s common stock reserved for issuance under the Section 423 Plan is reduced, on a one-for-one basis, by the number of shares of the Company&#8217;s common stock issued under the Plan.  The Plan was originally adopted by the Company&#8217;s Board of Directors on November 3, 2009.  Both the Plan and the Section 423 Plan have been most recently amended and restated in their entirety effective as of January 25, 2023. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; as used in the Plan means any entity that, directly or indirectly, is controlled by or under common control with the Company, as determined by the Board, whether now or hereafter existing. The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Related Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; as used in the Plan means any entity, other than an Affiliate, in which the Company has an equity or other ownership interest, as determined by the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Company, by means of the Plan, seeks to retain the services of employees in jurisdictions outside the United States, to secure and retain the services of new employees in such jurisdictions, and to provide incentives for such persons to exert maximum efforts for the success of the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Company does not intend for the rights to purchase shares of Common Stock granted under the Plan to qualify as options issued under an &#8220;employee stock purchase plan&#8221; as that term is defined in Section 423(b) of the Code. Accordingly, the Company will grant rights to purchase stock under the Plan that are not intended to meet the requirements of Section 423(b) of the Code, pursuant to rules, procedures or sub-plans adopted by the Company and designed to achieve tax, securities law or other objectives in one or more jurisdictions outside the United States, provided that (i) eligible employees (as that term is described in paragraph 5) who reside in the United States and are employed by the Company or an Affiliate located in the United States will not be granted rights to purchase stock under the Plan and (ii) eligible employees of Related Entities, whether or not located in the United States, will not be granted rights to purchase stock under the Section 423 Plan. Except to the limited extent otherwise provided herein, the purchase rights granted under the Plan will be subject to the same terms, provisions and restrictions as in effect for the purchase rights granted under the Section 423 Plan.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Plan shall be administered by the Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) of the Company unless and until the Board delegates administration to a Committee, as provided in subparagraph 2(c). Whether or not the Board has delegated administration, the Board shall have the final power to determine all questions of policy and expediency that may arise in the administration of the Plan. All determinations of the Board or the Committee shall be final, conclusive and binding on all persons and otherwise accorded the maximum deference permitted by law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Board shall have the power, subject to, and within the limitations of, the express provisions of the Plan&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(i) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To determine when and how rights to purchase stock of the Company shall be granted and the provisions to be in effect for each offering of such rights (with no need for the provisions of each offering to be identical).</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(ii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To designate from time to time which Affiliates and Related Entities shall be eligible to participate in the Plan.</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To construe and interpret the Plan and rights granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective. The Board may also authorize one or more designated officers of the Company to make such adjustments to the terms and conditions in effect under the separate Offerings made under the Plan as may be necessary or advisable to comply with applicable laws and regulations in the jurisdictions in which those Offerings are made. </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">       To amend the Plan as provided in paragraph 13.</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(v)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To adopt (or to authorize one or more designated officers of the Company to adopt) rules, procedures or sub-plans relating to the operation and administration of the Plan to accommodate the specific requirements of local laws and procedures for jurisdictions outside the United States. Without limiting the generality of the foregoing, the Board (or any such designated officer) is specifically authorized to adopt rules, procedures or sub-plans regarding, but not limited to, eligibility to participate, the definition of Earnings (as defined in subparagraph 7(b)), handling of payroll deductions, making of contributions to the Plan (including, without limitation, in forms other than payroll deductions), establishment of bank or trust accounts to hold contributions, payment of interest, conversion of local currency, obligations to pay payroll tax, withholding procedures and handling of stock certificates, all of which may vary with local requirements. </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(vi)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Board may delegate administration of the Plan to a committee composed of not fewer than two (2) members of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). If administration is delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the powers theretofore possessed by the Board, subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Board (or the Committee, as appropriate) may, from time to time, employ an entity unrelated to the Company to assist with administration, recordkeeping and other ministerial duties in connection with the Plan (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Third Party Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Shares Subject To The Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Subject to the provisions of paragraph 12 relating to adjustments upon changes in stock, the total number of shares that may be sold pursuant to rights granted under the Plan and the Section 423 Plan shall not exceed in the aggregate the 103,560,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:112%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> shares of Common Stock that have been approved by the Company&#8217;s stockholders for issuance under the Section 423 Plan. Accordingly, any shares of Common Stock sold pursuant to rights granted under the Section 423 Plan shall reduce, on a one-for-one basis, the number of shares available for sale and issuance under the Plan. If any right granted under the Plan shall for any reason terminate without having been exercised, the Common Stock not purchased under such right shall again become available for issuance under the Plan, unless otherwise issued under the Section 423 Plan. The Common Stock issuable under the Plan may be unissued shares or reacquired shares, bought on the market or otherwise. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Grant Of Rights&#59; Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Board or the Committee may from time to time grant or provide for the grant of rights to purchase Common Stock under the Plan to eligible employees (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) on a date or dates (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Offering Date(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) selected by the Board or the Committee. Each Offering shall be in such form and shall contain such terms and conditions as the Board or the Committee shall deem appropriate. The provisions of separate Offerings need not be identical, but each Offering shall include (through incorporation of the provisions of the Plan by reference in the Offering or otherwise) the substance of the provisions contained in paragraphs 5 through 8, inclusive.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Rights under the Plan may be granted only to employees of any Affiliate or Related Entity designated by the Board or the Committee as provided in subparagraph 2(b). Except as provided in subparagraph 5(b), an employee of any designated Affiliate or Related Entity shall not be eligible to be granted rights under the Plan, unless, on the Offering Date, such employee has been in the employ of one or more Affiliates or Related Entities for such continuous period preceding the grant date as the Board or the Committee may require, but in no event shall the required period of continuous employment be equal to or greater than two (2) years. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Board or the Committee may provide that, each person who, during the course of an Offering, first becomes an eligible employee of any designated Affiliate or Related Entity will, on a date or dates specified in the Offering which coincides with the day on which such person becomes an eligible employee or occurs thereafter, receive a right under that Offering, which right shall thereafter be deemed to be a part of that Offering. Such right shall have the same characteristics as any rights originally granted under that Offering, as described herein, except that&#58;</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;Share reserve  </font><font style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">consists of 4,000,000 shares authorized in November 15, 1991, when the Section 423 Plan was originally adopted, an additional 8,000,000 shares authorized for the Section 423 Plan on May 24, 1994, an additional 8,000,000 authorized for the Section 423 Plan on May 27, 1998, an additional 5,280,000 shares authorized for the Section 423 Plan on July 29, 1999, an additional 8,000,000 shares authorized for the Section 423 Plan on May 9, 2007, an additional 33,280,000 shares authorized for the Section 423 Plan on November 3, 2009, an additional 12,000,000 shares authorized on May 6, 2015, and an additional 25,000,000 shares to be submitted for stockholder approval and authorized at the Company&#8217;s 2023 annual meeting of stockholders. The share amounts so indicated have been adjusted to reflect the five (5) two-for-one stock splits of the Common Stock effected in February 2001, March 2002, September 2004, June 2007 and January 2013, respectively</font><font style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(i)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the date on which such right is granted shall be the &#8220;Offering Date&#8221; of such right for all purposes, including determination of the exercise price of such right&#59; </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(ii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the Offering Period (as defined in subparagraph 6(a)) for such right shall begin on its Offering Date and end coincident with the end of such Offering&#59; </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the Offering Date shall constitute the beginning of a Purchase Period&#59; and </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iv)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the Board or the Committee may provide that if such person first becomes an eligible employee within a specified period of time before the end of the Offering Period (as defined in subparagraph 6(a)) for such Offering, he or she will not receive any right under that Offering.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  No employee shall be eligible for the grant of any rights under the Plan if, immediately after any such rights are granted, such employee owns stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or of any Affiliate. For purposes of this subparagraph 5(c), the rules of Section 424(d) of the Code shall apply in determining the stock ownership of any employee, and stock which such employee may purchase under all outstanding rights and options shall be treated as stock owned by such employee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  An eligible employee may be granted rights under the Plan only if such rights, together with any other rights granted to such employee under &#8220;employee stock purchase plans&#8221; of the Company and any Affiliate, as specified by Section 423(b)(8) of the Code, do not permit such employee&#8217;s rights to purchase Common Stock of the Company or any Affiliate to accrue at a rate which exceeds U.S. twenty-five thousand dollars (U.S. $25,000) of fair market value of such Common Stock (determined at the time such rights are granted) for each calendar year in which such rights are outstanding at any time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Officers of any designated Affiliate or Related Entity shall be eligible to participate in Offerings under the Plan, provided, however, that the Board may provide in an Offering that all or certain employees who are highly compensated employees within the meaning of Section 423(b)(4)(D) of the Code shall not be eligible to participate.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Rights&#59; Purchase Price.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  On each Offering Date, each eligible employee, pursuant to an Offering made under the Plan, shall be granted the right to purchase the number of shares of Common Stock purchasable with up to twenty percent (20%) (or such other percentage as the Board or the Committee determines for a particular Offering) of such employee&#8217;s Earnings (as defined in subparagraph 7(b)) during the period which begins on the Offering Date (or such later date as the Board or the Committee determines for a particular Offering) and ends on the date stated in the Offering, which date shall be no more than twenty-seven (27) months after the Offering Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Offering Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). In connection with each Offering made under the Plan, the Board or the Committee shall specify a maximum number of shares which may be purchased by any employee and a maximum aggregate number of shares which may be purchased by all eligible employees pursuant to such Offering. Each Offering Period may contain more than one exercise date, as defined in the relevant Offering (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Exercise Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), in which case there will be multiple &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Purchase Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">,&#8221; the first commencing with the Offering Date and ending with the first Exercise Date of that Offering and subsequent ones commencing with the first day following the immediately preceding Exercise Date and ending with the next Exercise Date of that Offering. Where an Offering contains more than one Exercise Date, the Board or the Committee may, prior to the start of that Offering, specify a maximum number of shares which may be purchased by any employee on each such Exercise Date within such Offering and a maximum aggregate number of </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">shares which may be purchased by all eligible employees on such Exercise Date. If the aggregate purchase of shares upon exercise of rights granted under the Offering would exceed any such maximum aggregate number, the Board or the Committee shall make a pro rata allocation of the shares available in as nearly a uniform manner as shall be equitable and practicable under the circumstances. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The purchase price of Common Stock acquired pursuant to rights granted under the Plan shall be equal to eighty-five percent (85%) of the lower of&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(i)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the Fair Market Value per share of Common Stock on the start of the Offering Period&#59; or </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(ii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the Fair Market Value per share of Common Stock on the Exercise Date.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  As of any date, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; is defined as the closing sales price for the Common Stock (or the closing bid, if no sales were reported) on such day as quoted on The Nasdaq Global Select Market or as reported by such other source as the Board deems reliable. If there are no quotations for the relevant day, &#8220;Fair Market Value&#8221; is defined with reference to the most recent preceding date on which there are quotations. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Participation&#59; Withdrawal&#59; Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  An eligible employee may become a participant in an Offering by submitting an enrollment form to the Company, in a form approved by the Company, or, if made available by the Company to employees in a particular jurisdiction, by accessing the Third Party Administrator&#8217;s website and electronically enrolling within the Offering on or before his or her applicable Offering Date for that Offering (or any earlier enrollment deadline specified by the Company). During such enrollment process, the employee shall authorize payroll deductions of up to twenty percent (20%) (or such other percentage as the Board or the Committee determines for a particular Offering) of such employee&#8217;s Earnings (as defined in subparagraph 7(b) below) during the Offering Period. To the extent required by applicable law, eligible employees may be permitted to contribute to the Plan by means other than, or in addition to, payroll deductions. The contributions made by each participant (whether pursuant to payroll deductions or other method of payment) shall be credited to an account for such participant under the Plan and shall be deposited with the general funds of the Company, unless otherwise required by applicable law of any jurisdiction outside the United States. A participant may reduce, increase or begin such contributions after the beginning of any Offering Period only as provided for in the Offering. A participant may make additional payments into his or her account only (i) if required by applicable law or (ii) if specifically provided for in the Offering and only if the participant has not had the maximum amount contributed during the Offering Period.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#8220;Earnings&#8221; is defined as an employee&#8217;s total compensation, including (i) all salary, wages and other remuneration paid to the employee (including amounts elected to be deferred or contributed under any retirement or welfare benefit plan maintained by the Company or any participating Affiliate or Related Entity) and (ii) overtime pay, commissions, bonuses, profit sharing and any special payments for extraordinary services. However, &#8220;Earnings&#8221; shall not include the cost of employee benefits paid by the Company or any Affiliate or Related Entity, education or tuition fee reimbursements, imputed income arising under any group insurance or other employee benefit program, reimbursement of traveling, business or moving expenses, income realized in connection with stock options or other equity awards, amounts elected to be deferred under any nonqualified deferred compensation plan established by the Company or any Affiliate or Related Entity and referral pay which is paid in recognition of referring an employee candidate. However, the Board or its delegate in its sole discretion may make one or more modifications to such definition with respect to eligible employees who participate in the Plan. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  At any time during an Offering Period a participant may terminate his or her contributions under the Plan and withdraw from the Offering by submitting a withdrawal notice to the Company or, if made available by the Company to employees in a particular jurisdiction, by accessing the Third Party Administrator&#8217;s website and electronically electing to withdraw. Such withdrawal may be elected at any time prior to the end of the Purchase Period (or any earlier withdrawal deadline specified by the Company). Upon such withdrawal from the Offering by a participant, the Company shall distribute to such participant all of his or her accumulated contributions (reduced to the extent, if any, such contributions have been used to acquire shares for the participant) under the Offering, without interest unless the terms of the Offering specifically so provide or if required by applicable law, and such participant&#8217;s interest in that Offering shall be automatically terminated. A participant&#8217;s withdrawal from an Offering will have no effect upon such participant&#8217;s eligibility to participate in any other future Offerings under the Plan but such participant will be required to re-enroll in order to participate in subsequent Offerings under the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Except as provided in Section 7(f) below, rights granted pursuant to any Offering under the Plan shall terminate immediately upon cessation of any participating employee&#8217;s employment with the Company or any participating Affiliate or Related Entity, for any reason, and the Company shall distribute to such terminated employee all of his or her accumulated contributions (reduced to the extent, if any, such contributions have been used to acquire shares for the terminated employee) under the Offering, without interest unless the terms of the Offering specifically so provide or if required by applicable law. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Should a participating employee cease to remain in active service by reason of an approved unpaid leave of absence, then such employee shall have the right, exercisable up until the last business day of the Purchase Period (or any earlier deadline specified by the Company) in which such leave commences, to (a) withdraw all the contributions collected to date on his or her behalf for that Purchase Period or (b) have such funds held for the purchase of shares on his or her behalf on the next scheduled Exercise Date. If the participating employee fails to make a timely election, such funds will automatically be applied to the purchase of shares on his or her behalf on the next scheduled Exercise Date. In no event, however, shall any further contributions be collected on the employee&#8217;s behalf during such leave, except to the extent required by applicable law. Upon the participating employee&#8217;s return to active service (i) within three (3) months following the commencement of such leave or (ii) prior to the expiration of any longer period for which such employee had reemployment rights with the Company (or any Affiliate or Related Entity) provided by either statute or contract, his or her contributions under the Plan shall automatically resume at the rate in effect at the time the leave began, unless the employee withdraws from the Plan prior to his or her return. An employee who returns to active employment following a leave of absence that exceeds in duration the applicable time period set forth in (i) or (ii) above shall be treated as a new employee for purposes of subsequent participation in the Plan and must accordingly re-enroll in the Plan in order to participate in subsequent Offerings under the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Notwithstanding anything to the contrary contained herein, a participating employee who transfers employment from the Company or any Affiliate participating in the Section 423 Plan to an Affiliate or Related Entity participating in the Plan shall immediately cease to participate in the Section 423 Plan. However, his or her accumulated contributions for the Purchase Period in which such transfer occurs shall be transferred to the Plan, and such individual shall immediately join the then current Offering under the Plan upon the same terms and conditions in effect for his or her participation in the Section 423 Plan, except for such modifications as may be required by applicable law. A participating employee who transfers employment from an Affiliate or Related Entity participating in a current Offering under the Plan to the Company or any other Affiliate participating in the Section 423 Plan shall remain a participant in the Plan until the earlier of (i) the end of the current </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Offering Period under the Plan or (ii) the start date of the first Offering under the Section 423 Plan in which he or she participates following such transfer.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Rights granted under the Plan shall not be transferable by a participant otherwise than by will or the laws of descent and distribution and, during his or her lifetime, shall be exercisable only by the person to whom such rights are granted.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Exercise and Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  On each Exercise Date, each participant&#8217;s accumulated contributions (without any increase for interest unless the terms of the Offering specifically so provide or if required by applicable law) will be applied to the purchase of shares of Common Stock of the Company, up to the maximum number of shares permitted pursuant to the terms of the Plan and the applicable Offering, at the purchase price specified in the Offering.  No fractional shares shall be issued upon the exercise of rights granted under the Plan unless otherwise determined by the Board or the Committee.  The amount, if any, of remaining accumulated contributions after the purchase of shares which is less than the amount required to purchase one share of Common Stock on any current Exercise Date within an Offering shall be refunded to such participant as soon as administratively practicable following such Exercise Date, without interest unless the terms of the Offering specifically so provide or if required by applicable law. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  No rights granted under the Plan may be exercised to any extent unless the Plan (including rights granted thereunder) is covered by an effective registration statement pursuant to the U.S. Securities Act of 1933, as amended. If on an Exercise Date of any Offering hereunder the Plan (and all rights granted thereunder) is not so registered, no rights granted under the Plan or any Offering shall be exercised on such Exercise Date, and all contributions accumulated during the Purchase Period ending on such Exercise Date (reduced to the extent, if any, such contributions have been used to acquire shares) shall be distributed to the participants, without interest unless the terms of the Offering specifically so provide or required by applicable law. In addition, should the Plan not be registered on any applicable Exercise Date in any jurisdiction outside the United States in which such registration is required or should the Plan or the purchase of shares thereunder otherwise not at that time comply with applicable law in a jurisdiction outside the United States, then no rights granted under the Plan to employees in that jurisdiction shall be exercised on such Exercise Date, and all contributions accumulated on behalf of such employees during the Purchase Period ending with such Exercise Date (reduced to the extent, if any, such contributions have been used to acquire shares) shall be distributed to the participating employees in that jurisdiction without interest, unless the terms of the Offering specifically so provide or if required by applicable law. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(c)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">As soon as administratively practicable following the Exercise Date, the Company shall deliver to each participant the shares of Common Stock purchased with such participant&#8217;s accumulated contributions in a form determined by the Board or the Committee, in its discretion, including, without limitation, through the transfer of the shares to the participant in book-entry form or through an alternative arrangement to a recordkeeping service (and the Board or the Committee may either require or permit participants to elect that certificates representing such shares be delivered to such recordkeeping service).  The Board or the Committee, in its discretion, may either require or permit that shares of Common Stock purchased with each participant&#8217;s accumulated contributions be deposited directly with a broker designated by the Board or the Committee (or its delegate) and may either require or permit that such shares be retained with such broker for a designated period of time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Covenants Of The Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  While rights granted under the Plan remain outstanding, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such rights.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Company shall seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to issue and sell shares of Common Stock upon exercise of the rights granted under the Plan. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of shares under the Plan, the Company shall be relieved from any liability for failure to issue and sell shares upon exercise of such rights unless and until such authority is obtained.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Accumulated Contributions.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A participant&#8217;s accumulated contributions shall be maintained as part of the general funds of the Company and shall not earn interest, except to the extent otherwise provided by the terms of the Offering or as otherwise required to comply with applicable law of any jurisdiction outside the United States.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Rights As A Stockholder.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A participant shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares subject to rights granted under the Plan unless and until certificates representing such shares shall have been issued or recorded in the books of the Company (or its transfer agent).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Adjustments Upon Changes In Stock.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  If any change is made in the securities subject to the Plan, or subject to any rights granted under the Plan (through merger, consolidation, reorganization, recapitalization, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or otherwise), the Plan and the outstanding rights thereunder will be appropriately adjusted as to the class(es) and maximum number of securities subject to the Plan and the class(es) and number of securities and price per share subject to each outstanding purchase right.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  In the event of a Change in Control (as such term is defined in the Gilead Sciences, Inc. 2022 Equity Incentive Plan or any successor plan thereto), then, as determined by the Board in its sole discretion (i) any surviving corporation may assume outstanding rights or substitute similar rights for those under the Plan, (ii) such rights may continue in full force and effect, (iii) the accumulated contributions may be used to purchase shares of Common Stock immediately prior to the transaction described above and the rights of participants under the ongoing Offering shall be terminated, or (iv) all outstanding Offering Periods may be terminated immediately as of such date specified by the Board and all participants&#8217; accumulated contributions that have not been used to purchase shares of Common Stock be returned to the participants (without interest unless the terms of the Offering specifically so provide) as soon as administratively practicable thereafter. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Amendment Of The Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Board at any time, and from time to time, may amend the Plan, including to re-combine the Plan with the Section 423 Plan. However, except as provided in paragraph 12 relating to adjustments upon certain changes to the Common Stock, no amendment shall be effective unless approved by the stockholders of the Company within twelve (12) months before or after the adoption of the amendment, where the amendment will&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(i)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Increase the total number of shares reserved for issuance and sale in the aggregate under the Plan and the Section 423 Plan&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(ii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Materially modify the provisions as to eligibility for participation in the Plan (to the extent such modification requires stockholder approval in order for the Plan to comply with applicable Nasdaq or securities exchange listing requirements) or otherwise materially expand the class of employees eligible to participate in the Plan&#59; or </font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(iii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Modify the Plan in any other way if such modification requires stockholder approval in order to comply with any applicable Nasdaq or securities exchange listing requirements.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Board may, in its sole discretion, submit any other amendment to the Plan for stockholder approval. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide eligible employees with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated thereunder relating to employee stock purchase plans, or under applicable laws of any jurisdiction outside the United States.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Rights and obligations under any rights granted before amendment of the Plan shall not be materially adversely altered or impaired by any amendment of the Plan, except with the consent of the person to whom such rights were granted or except as necessary to comply with applicable laws or governmental regulations.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Section 409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Plan is intended to be exempt from Section 409A of the Code under the short-term deferral exception, and any ambiguities shall be construed and interpreted in accordance with such intent. In the case of a participant who would otherwise be subject to Section 409A of the Code, to the extent an option to purchase shares of Common Stock or the payment, settlement or deferral thereof is subject to Section 409A of the Code, the option to purchase shares of Common Stock shall be granted, paid, exercised, settled or deferred in a manner that will comply with Section 409A of the Code, including the final regulations and other guidance issued with respect thereto. Notwithstanding the foregoing, the Company shall have no liability to a participant or any other party if the option to purchase shares under the Plan that is intended to be exempt from or compliant with Section 409A of the Code is not so exempt or compliant or for any action taken by the Board or the Committee with respect thereto. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Tax Withholding.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company or any Affiliate or Related Entity shall have the authority and right to deduct and withhold, including from the participant&#8217;s regular salary, or require each such participant to remit to the Company or such Affiliate or Related Entity, an amount sufficient to satisfy U.S. federal, state and local taxes and taxes imposed by jurisdictions outside the United States (including income tax, social insurance contributions, payroll taxes and any other taxes that may be due) required by law to be withheld with respect to any taxable event concerning a participant arising as a result of his or her participation in the Plan or to take any such action as may be necessary in the opinion of the Company or any Affiliate or Related Entity, as appropriate, to satisfy withholding obligations for the payment of taxes. In no event shall any shares be issued hereunder to any participant until the participant has made arrangements acceptable to the Company for the satisfaction of any applicable tax obligations with respect to any taxable event concerning the participant&#8217;s participation in the Plan. Each Participant, however, shall be responsible for payment of all individual tax liabilities arising under the Plan</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Termination Or Suspension Of The Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate on January 25, 2033, or, if earlier, when the Section 423 Plan is terminated. No rights may be granted under the Plan while the Plan is suspended or after it is terminated.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Rights and obligations under any rights granted while the Plan is in effect shall not be impaired by suspension or termination of the Plan, except as expressly provided in the Plan or with the consent of the person to whom such rights were granted, or except as necessary to comply with applicable laws or governmental regulation.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If any particular provision of the Plan is found to be invalid or unenforceable, such provision shall not affect the other provisions of the Plan, but the Plan shall be construed in all respects as if such invalid provision had been omitted.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Except to the extent that provisions of the Plan are governed by applicable provisions of the Code or any other substantive provision of U.S. federal law, the Plan shall be construed in accordance with, and shall be governed by, the substantive laws of the State of Delaware without resort to Delaware&#8217;s conflict-of-laws rules. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Effective Date Of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Plan originally became effective with the offering commencing January 1, 2010. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>gild-20230503.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d514cf5c-b880-44be-997f-54690199e6c4,g:a54f0be9-39c2-46b5-91a9-6713ada5b3a2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gild="http://www.gilead.com/20230503" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gilead.com/20230503">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20230503_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20230503_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverCover" roleURI="http://www.gilead.com/role/CoverCover">
        <link:definition>0000001 - Document - Cover Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>gild-20230503_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d514cf5c-b880-44be-997f-54690199e6c4,g:a54f0be9-39c2-46b5-91a9-6713ada5b3a2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_b22aad13-c289-44dc-a85a-8728230a83da_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_847d73b3-5b9a-4d5b-8ee4-bfce794bc9d8_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_f4df622b-be99-433f-8ab4-e84135f49464_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cfc4cd73-d774-4a4b-be4c-0446507fef6c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_976ac870-8fa4-43a2-9165-d23c12718eb1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8d2cb957-ac73-497d-be66-c91d7c3dc1ef_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f492f64d-5b16-404f-a419-40ccca3b9de0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_b9a473c2-1613-49b8-a3d0-d93d548f2acd_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8ea6b57a-c7d2-425d-bf04-67bbf174a3fa_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_5e40f24a-3d0a-4cf5-af7b-7bb26326c589_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ab435110-c2f4-4560-83f4-baa3e3fa3f60_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_0b80000d-bf0c-43c2-ba53-342fc9040c09_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ed5d526b-585a-458e-99c9-26246c6ad29e_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_eacd5517-7c01-46a3-a2d3-976be32d5e51_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c384bddc-133e-4296-8a52-1b7f5fc1c84b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c3b3661c-1401-4ec7-8f40-829b3d0f63da_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0812df99-1254-45c7-aa79-53b26959787f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_341f1548-70e7-44d8-8024-dcacf040a358_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c98d7c3f-e96d-471c-a460-8140366184a1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_21081cc1-6c2f-4a08-b964-0c19340128a3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_95d41f1d-6a42-4949-a8f4-f48672d3b0f4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1bb95f66-2308-44c1-a2d8-f8015285ef4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_776e3d50-c054-4114-b799-c1e150575b8c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>gild-20230503_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d514cf5c-b880-44be-997f-54690199e6c4,g:a54f0be9-39c2-46b5-91a9-6713ada5b3a2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gilead.com/role/CoverCover" xlink:type="simple" xlink:href="gild-20230503.xsd#CoverCover"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CoverCover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_623f24f5-c66d-4a56-8856-424e4e92f7fb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_DocumentType_623f24f5-c66d-4a56-8856-424e4e92f7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_24c4f5c8-9d6b-4934-bf5d-ffaff68d58a3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_DocumentPeriodEndDate_24c4f5c8-9d6b-4934-bf5d-ffaff68d58a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5564316e-89bd-4abf-9fd6-ff626efd4378" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityRegistrantName_5564316e-89bd-4abf-9fd6-ff626efd4378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f299cefd-058b-45a9-a5ff-8b72bbe1e596" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f299cefd-058b-45a9-a5ff-8b72bbe1e596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c266a421-2acd-4a2b-a28a-40b8b34efbef" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityFileNumber_c266a421-2acd-4a2b-a28a-40b8b34efbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b0339bbf-0500-4825-a72d-951bbe06ce0f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityTaxIdentificationNumber_b0339bbf-0500-4825-a72d-951bbe06ce0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a17d9075-93b1-4206-aa0d-bc4c7b98a752" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityAddressAddressLine1_a17d9075-93b1-4206-aa0d-bc4c7b98a752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_bb83edc8-b0d7-40fc-a994-e0fa0226611e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityAddressCityOrTown_bb83edc8-b0d7-40fc-a994-e0fa0226611e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_dbc2efa8-8acc-4aa5-b01b-c6eff8626f86" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityAddressStateOrProvince_dbc2efa8-8acc-4aa5-b01b-c6eff8626f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c8735215-0f7a-4602-9635-be872960fd6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityAddressPostalZipCode_c8735215-0f7a-4602-9635-be872960fd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_37430ae0-844f-4d92-b4a9-23b384ec473c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_CityAreaCode_37430ae0-844f-4d92-b4a9-23b384ec473c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8a2e1012-5ac8-437b-96be-09467f013ceb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_LocalPhoneNumber_8a2e1012-5ac8-437b-96be-09467f013ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_7988370c-64a1-4fdd-8b8d-a89342a727e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_WrittenCommunications_7988370c-64a1-4fdd-8b8d-a89342a727e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_12e74e46-842f-4f3e-89cf-fc6193da75bc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_SolicitingMaterial_12e74e46-842f-4f3e-89cf-fc6193da75bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_cf17551e-75f8-4bff-80e9-90c6b4f7ec2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_PreCommencementTenderOffer_cf17551e-75f8-4bff-80e9-90c6b4f7ec2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_be1a824a-de36-4d75-914e-8be608da5119" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_be1a824a-de36-4d75-914e-8be608da5119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8870a81d-d2a7-474d-9ea3-675bc10bb760" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_Security12bTitle_8870a81d-d2a7-474d-9ea3-675bc10bb760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a8bd7bc2-ff34-4edf-a605-2a7e1710d261" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_TradingSymbol_a8bd7bc2-ff34-4edf-a605-2a7e1710d261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2dd0c1a7-392e-43ea-8af0-a9cf0b31fae8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_SecurityExchangeName_2dd0c1a7-392e-43ea-8af0-a9cf0b31fae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_72380ccd-0ac2-43bb-afd6-cddb57557a2b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityEmergingGrowthCompany_72380ccd-0ac2-43bb-afd6-cddb57557a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_46deacf5-5bb9-4ab4-b507-2e859b33dc72" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_EntityCentralIndexKey_46deacf5-5bb9-4ab4-b507-2e859b33dc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e9ffccdd-c38e-42d4-a7a1-dd0ed91a71ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8991db35-01bb-4b0e-864b-d6434416e9b0" xlink:to="loc_dei_AmendmentFlag_e9ffccdd-c38e-42d4-a7a1-dd0ed91a71ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139893917112416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Cover<br></strong></div></th>
<th class="th"><div>May 03, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  03,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GILEAD SCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-19731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3047598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">333 Lakeside Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">574-3000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value, $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GILD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>gild-20230503_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gild-20230503.xsd" xlink:type="simple"/>
    <context id="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <startDate>2023-05-03</startDate>
            <endDate>2023-05-03</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF80L2ZyYWc6ZTBhZDUwODIwYTMyNGY2MWE4YWJlOTUxMzQ2MzY2NjEvdGFibGU6OGFlODg2YjZjMjQyNGQwMWE4Y2EwZmQxM2MzODdkY2MvdGFibGVyYW5nZTo4YWU4ODZiNmMyNDI0ZDAxYThjYTBmZDEzYzM4N2RjY18xLTEtMS0xLTMwODQ4Mg_d5d383e6-3224-4ae4-8c80-c6aaea7262d0">0000882095</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF80L2ZyYWc6ZTBhZDUwODIwYTMyNGY2MWE4YWJlOTUxMzQ2MzY2NjEvdGFibGU6OGFlODg2YjZjMjQyNGQwMWE4Y2EwZmQxM2MzODdkY2MvdGFibGVyYW5nZTo4YWU4ODZiNmMyNDI0ZDAxYThjYTBmZDEzYzM4N2RjY18yLTEtMS0xLTMwODQ4Mg_d43ad4c9-f3f2-4bb9-bff0-fea90e469551">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV84OQ_2dd9e29f-d8d1-4f12-b6cc-00d4a7f0ec0f">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV81NDk3NTU4MTc1NjM_a7e3584b-4307-4fae-9cb8-52e571cca145">2023-05-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8yNDA_b0454b7d-d408-40d1-97f6-5c64dc915cba">GILEAD SCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6NDI5NDliMzBlY2JjNGJhMDg4MzU5Mjk3Y2VlZmQ1YWYvdGFibGVyYW5nZTo0Mjk0OWIzMGVjYmM0YmEwODgzNTkyOTdjZWVmZDVhZl8wLTAtMS0xLTMwODQ4Mg_fe821509-fe5e-41f0-9ac0-5935f1f3cd75">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6NDI5NDliMzBlY2JjNGJhMDg4MzU5Mjk3Y2VlZmQ1YWYvdGFibGVyYW5nZTo0Mjk0OWIzMGVjYmM0YmEwODgzNTkyOTdjZWVmZDVhZl8wLTEtMS0xLTMwODQ4Mg_f0442b00-67e0-4f13-846e-a2806215d093">0-19731</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6NDI5NDliMzBlY2JjNGJhMDg4MzU5Mjk3Y2VlZmQ1YWYvdGFibGVyYW5nZTo0Mjk0OWIzMGVjYmM0YmEwODgzNTkyOTdjZWVmZDVhZl8wLTItMS0xLTMwODQ4Mg_587615b2-4633-4a8b-8eb8-76240009b9f7">94-3047598</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zMDI_b6d81d9e-3780-4723-932b-ae43e8e96126">333 Lakeside Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zMDY_93abd0e1-872e-4f82-9cd7-3d6e37594905">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zMTA_1e19fdc0-b35d-4fc1-85fa-92d54a55b5b0">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNTU_faa03282-1d12-4e28-ba69-3506c3211ad2">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNzA_f06f9b25-4471-407f-83ba-628e562d4de6">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNzM_6d5870d3-156f-4f7d-8e5c-3fd060859b5e">574-3000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjYx_63ef027e-f08e-4b6c-aeec-0485a1a10a68">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjYy_9843df0c-f3be-4122-9242-502f01d2ef06">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjYz_5f61a772-0d4d-4c3f-a4fb-1f7833297d33">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjY0_d47f46c6-74f6-420b-b43f-069db62b227f">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6MDFkYWVkZjQwN2JmNGJlMmJjYzJiNmI3MThmZWUzNmEvdGFibGVyYW5nZTowMWRhZWRmNDA3YmY0YmUyYmNjMmI2YjcxOGZlZTM2YV8xLTAtMS0xLTMwODQ4Mg_67f5ba89-c816-4a3b-a62b-20fce0eea628">Common Stock, par value, $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6MDFkYWVkZjQwN2JmNGJlMmJjYzJiNmI3MThmZWUzNmEvdGFibGVyYW5nZTowMWRhZWRmNDA3YmY0YmUyYmNjMmI2YjcxOGZlZTM2YV8xLTItMS0xLTMwODQ4Mg_555c596f-197f-4c76-acac-d02071694e0e">GILD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGFibGU6MDFkYWVkZjQwN2JmNGJlMmJjYzJiNmI3MThmZWUzNmEvdGFibGVyYW5nZTowMWRhZWRmNDA3YmY0YmUyYmNjMmI2YjcxOGZlZTM2YV8xLTQtMS0xLTMwODQ4Mg_8f295490-0041-4c94-9faf-95a682ee322d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV8zNjU4_1d7975ba-9b4e-4705-8b4f-dce5dd6a3725">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentPeriodEndDate
      contextRef="ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzM2ViYmM1YTA5MTRjNGRiNDNjMWQ4NzZlMTZiNDM0L3NlYzo4MzNlYmJjNWEwOTE0YzRkYjQzYzFkODc2ZTE2YjQzNF8xL2ZyYWc6NzlhYjMzYWEwMzQ4NGRiMzg0Njk2NGU1MTUwZmY2OTUvdGV4dHJlZ2lvbjo3OWFiMzNhYTAzNDg0ZGIzODQ2OTY0ZTUxNTBmZjY5NV81NDk3NTU4MzM0NDg_a7e3584b-4307-4fae-9cb8-52e571cca145">2023-05-03</dei:DocumentPeriodEndDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M@6#Z7F6QWG>!3FP+)MRSW(E:T\7E[J0VUK-!!<,[60'\[\(K"V*AY"L74>U
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M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ ZUFE5I>*NQS
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( .M9I5;S3H/P1P0  (,0   8
M          " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " #K6:56GZ ;\+$"  #B#   #0              @ &)#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( .M9I5:7BKL<P    !,"   +
M  "  64/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .M9I58"WH(#-@$  "@"
M   /              "  4X0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" #K6:56)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #K6:5699!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="gild-20230503.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CoverCover</Role>
      <ShortName>Cover Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="gild-20230503.htm">gild-20230503.htm</File>
    <File>ex1012023employeestockpurc.htm</File>
    <File>ex1022023internationalempl.htm</File>
    <File>gild-20230503.xsd</File>
    <File>gild-20230503_lab.xml</File>
    <File>gild-20230503_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "gild-20230503.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "gild-20230503.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gild-20230503_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gild-20230503_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "gild-20230503.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "gild",
   "nsuri": "http://www.gilead.com/20230503",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20230503.htm",
      "contextRef": "ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.gilead.com/role/CoverCover",
     "shortName": "Cover Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20230503.htm",
      "contextRef": "ic85a33ee8f2145ef90d39c2a8e51a9f8_D20230503-20230503",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000882095-23-000019-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000882095-23-000019-xbrl.zip
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MRWET?! /!M%"K*.)C&;J1F8P7I0OX3"J.E/5F@[9\$A)+*,926\"?EO6 G8
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MTH&)Q&Q6L)N&?QT?G0S/GAP-8>N^"'V<CYKM);H-N)8H1((X/!WAT8 /0*D
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MF,0?7VM,5&PCET%OC38[X'LF>7Y]"%18K'F2-!D>"VVO5,>:L'>Z!U-'%B1
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M8[\8\U2Y!*M^"/8]^%,)(U/=0'Q#I:TI80%">%[>&>\SLU?8*J18Y@7?&E.
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M KHUY]DLQSUKXQE<,?20H? W@]:5M T\O5V;5T@=W"U<VC@(WY?5+%9E6G!
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M\]M8"XU77[8N/@HD@)!<@8J"S7+6DZ=;75[DZ*QF!<Q^[[,0$Z5M)31(E>M
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MI<<]+&F[="GZ8VCP$3)"@M!-4[I#6^OH:2SE3%,>AO,1#\[)$2WI1+4\P0P
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ML!9"8;*5=&]"_$]CXQZCB7M\M(;/[IC#\.&D2*_A7_-ZD7W__U!+ P04
M" #K6:56^E/:96$?  !?30$ $0   &=I;&0M,C R,S U,#,N:'1M[3UM5]K*
MUM_OKYB'^SSW]JR5X.0]H:UW6:$>>P1;Q7KQ2]<D,Y%H2#A)4/'7/WLF 4&Q
M@F^ INN<%LAD7O;[WK-GSZ?_7/5"=,&2-(BCSQ6EBBOH/YN?_D>6__OE8 _5
M8V_08U&&MA-&,D;199!UT3%EZ3GRD[B'CN/D/+@@LBS>V8[[PR0X[69(Q:IV
MZV%2HX:B>[[AR:YM8UG7728[CN7+AFXZ6'$<9GJZ=%HCANYCESFRYGBJK)NN
M(3L*<6334C1"B>%J1)5HS=8TYKJ>0; #W>K4U35/H;9E,L6$SSH?MIO!ZF"%
M45H+KK+/E6Z6]6L;&Y>7E]4K-PFK<7*Z$41A$#&^W(TL(5'JQTF/9 ".#5@$
MEK$J*VJEZ.0*FIY/=7.IB4Y@]LZ&>%JY&4].F3?5&+Y73^.+WPZI&#*V94TI
M^KE_,+ZV\;Q@,<'LY:D8:S!@FI'(8Z/V=Y8QW9P_=DDZ;GZ5!K/F 6V5C?\V
M]PZ]+NL1^?8@E-V\)?H?+1\><-AJ-Z"Z;RZ*-@$KT;P6DNCT<X5%\M%A!1#,
M"-W\U&,90;P'F?T]""X^5[;C* .RE=O#/DS'R[]]KF3L*ML0<-O8_,<__O$I
M"[*0;9X&(97Y?+"!M4\;^8^?-O*NW9@.-S_1X *EV3!DGRLT2/LA&=:B.&(P
M@>"JQANR)/\84,HB\1&>MX!WDL#+Q[_*#IC_N1)XMD& <IGMJXIN,-_!E-,Y
ML9D!1.[;O^JCJ8SG5$$1Z?&A65!K1#"_X38L)R'A;D39U5]L6$$!A:ZI]G/H
MUN.+/?7@HJ,U!_2L<7&RXYSMGYU>-]6?0:?75#KM+:/9/CAK[1P$K7KKK'G\
M0V]=GX3-]@E\;^(]K15VKF.]>0W_]KZ=M8X;E_OM!NY<'YQWSGY<=ZZ_GN_7
M/?6DW5#Y]]97&^^I)\/.L6>>M+]T3^I'E_OUW<M.NSEL[734YG%#[QQ_"_?;
M1U?-ZQ]J\[JCMF!>=.=KX.X<F?L[7\/]^BGT=7+6//L![_RX%.^HC<N3WH^K
M)KRQ7Z?GT%/QSD\8RXA.VC'T>Z3OUV'>/1BKOHM/ZEM7G7;WK-/^TCNI-V"N
M3;VE'IQU%/MJK]W(FH<8_FW"_'[HS=-?U*":K3%3UE15EW7"=-GV0#!Y)B&,
M6*JI4ES9Q/#'ME7L&)\VIM#ZDEC> J%+N>#]&I+3$KL/87<X"[LZ* O=<V1?
M\T&+N*XCN[Z/99\1!S/0.(:A5#9]$J;L#F(WIEDY83Y+&$BV=(8$XK*RE@H)
M"*A'0@?4,I [GRMIT.N'7!R*W[H)IXPI85.]2BETL3'=1S[^S:#%'-)XD(AO
M0MC7"G++:>,QY#;JB F),OH64/[=#UB"Q(383 6VO?O7-&?<?GES]--T[WV
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M!-L^!Q>\!XOB@/I< =$YO>YB)= 2T7C X?)/+/Y\[!-*@^BTAI$BNKD99T/
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M$>!C75==C&738IA'8C79UDTF$]7&)I QQ8Y6V<2RXEB:4M+JDVBU3:YVBV0
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ML*'E625C/57L7(S-+R_/2Q%"4.B\+,SUT 4'86&/38\OP0"*HDJ:X\  >#2
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M<WXKQEY.T:6=M[C;;!N2CFU)668I@_=@Z:F"0DL#[Q$DJEN2C<LMII?U]YY
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MUP_C(6- /] Q^CY(/$ R$%4HT$!_\^HNCR'E%[H#KG[741G-*J-9;\6**/-
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M^G9U[+$--Z9#^ =<G'#S_P%02P,$%     @ ZUFE5KJI>W!K @  > <  !$
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MB@YVL3#X4B+4D0)9:9)_OZ3\B!1+-DG%&FT_-(Y]=7GNB<[EO23EU[_>7R_
M3UDNLR)_<^*_]$Z S'DALOSRS<FWBP\P.?GU[8L7K_\"X1__^'H&?BOX[;7,
M*W!:2EI) >ZRZ@I\%W+Y Z1E<0V^%^6/[">%\&U]T6EQ\U!FEU<50!X*GGY:
MOA*ACWD:<LB2Q(,8,PD)B5,8XHAX/B$RXOB7RU<TQ*G')($!X0CBB(60^)3
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M;WEE97-T;V-K<'5R8RYH=&U02P$"% ,4    " #K6:56:*!:3"XM  "I) $
M'@              @ $T+   97@Q,#(R,#(S:6YT97)N871I;VYA;&5M<&PN
M:'1M4$L! A0#%     @ ZUFE5OI3VF5A'P  7TT! !$              ( !
MGED  &=I;&0M,C R,S U,#,N:'1M4$L! A0#%     @ ZUFE5KJI>W!K @
M> <  !$              ( !+GD  &=I;&0M,C R,S U,#,N>'-D4$L! A0#
M%     @ ZUFE5OT,E;!M"@  25X  !4              ( !R'L  &=I;&0M
M,C R,S U,#-?;&%B+GAM;%!+ 0(4 Q0    ( .M9I59=VO&/JP8  .<P   5
M              "  6B&  !G:6QD+3(P,C,P-3 S7W!R92YX;6Q02P4&
/  8 !@"< 0  1HT

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
